Investigating the effect of dexmedetomidine in preventing delirium after esophagectomy surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N42

Enrollment

Registered

2024-01-07

Start date

2024-01-19

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitation. Restlessness and agitation

Interventions

Intervention 1: Intervention group: Patients will be randomly assigned to this group. Immediately after the induction of anesthesia, the patients will receive the intervention. Dexmedetomidine will be

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Candidate for esophagectomy surgery The duration of the surgery is between three and five hours Same anesthesia method for all patients

Exclusion criteria

Exclusion criteria: Body mass index greater than 30 ASA class above III Heart rate less than 50 beats per minute Allergy to dexmedetomidine

Design outcomes

Primary

Measure	Time frame
Agitation. Timepoint: Three times in three days and once every day. Method of measurement: Examination by a neurologist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Khanbabayi Gol

Tabriz University of Medical Sciences

Khanbabayimehdi69@gmail.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026